Bone Diseases in Patients with Chronic Liver Disease

Area of Science:

• Hepatology
• Endocrinology
• Immunology

Background:

• Osteoporosis is a significant complication in chronic liver disease (CLD), affecting patients with cirrhosis, cholestatic conditions, and liver transplants.
• While common, bone diseases in frequently occurring CLDs like viral hepatitis, NAFLD, and alcoholic liver disease are understudied.
• Osteoporosis results from an osteoblast/osteoclast imbalance, influenced by immune cells, chronic inflammation, and gut microbiota.

Purpose of the Study:

• To review bone diseases in patients with chronic liver disease.
• To highlight special considerations including liver transplants, hepatitis B treatment, sarcopenia, and avascular necrosis.
• To emphasize the need for management guidelines for low bone mineral density in CLD.

Main Methods:

• Literature review focusing on osteoporosis in various chronic liver diseases.
• Analysis of the interplay between immune cells, inflammation, gut microbiota, and bone metabolism.
• Examination of specific patient populations and associated bone conditions.

Main Results:

• Chronic liver disease significantly increases osteoporosis risk, particularly in specific conditions and post-transplant.
• Complex mechanisms involving inflammation, immune responses, and gut dysbiosis contribute to bone loss.
• Existing guidelines for managing bone diseases in CLD are scarce.

Conclusions:

• The pathogenesis of osteoporosis in CLD is multifactorial and not fully elucidated.
• Management of bone health is critical due to increased life expectancy in CLD patients.
• Development of specific clinical guidelines for osteoporosis in CLD is urgently needed.